GB Patent

GB2109231A — Medicament containing progesterone

Assigned to Individual · Expires 1983-06-02 · 43y expired

What this patent protects

A medicament, for the treatment of mammary disorders such as mastodynias and mastopathias, is in the form of a gel containing progesterone and is administered percutaneously.

USPTO Abstract

A medicament, for the treatment of mammary disorders such as mastodynias and mastopathias, is in the form of a gel containing progesterone and is administered percutaneously.

Drugs covered by this patent

Patent Metadata

Patent number
GB2109231A
Jurisdiction
GB
Classification
—
Expires
1983-06-02
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.